Ranitidine is a competitive inhibitor of histamine H2-receptors. The reversible inhibition of H2-receptors in gastric parietal cells results in a reduction in both gastric acid volume and concentration.
| Cas No : | 66357-35-5 |
|---|---|
| Name : | Ranitidine |
| Synonyms : | N-(2-[(5-[(Dimethylamino)methyl]furan-2-yl)methylthio]ethyl)-N’-methyl-2-nitroethene-1,1-diamine |
| Molecular Formula : | C13H22N4O3S |
| Melting Point : | 133-134°C |
| Boiling Point : | 437.1±45.0 °C at 760 mmHg |
| Molecular Weight : | 314.404 g/mol |
| Density : | 1.2±0.1 g/cm3 |
| Solubility : | Soluble in water (1.8 mg/mL), 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin (7.0 mg/mL), acetic acid, methanol, ethanol (<1 mg/mL). |
Advancing global health through high-quality APIs, intermediates, and surgical products. Trusted solutions driven by innovation, quality, and care.
Copyright © 2025 Healnith Pharmaceuticals All rights reserved.